UK markets closed

GH Aug 2022 40.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.4000-0.7000 (-13.73%)
As of 10:06AM EDT. Market open.
Full screen
Previous close5.1000
Open4.4000
Bid3.6000
Ask3.9000
Strike40.00
Expiry date2022-08-19
Day's range4.4000 - 4.4000
Contract rangeN/A
Volume2
Open interest142
  • Business Wire

    Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture

    PALO ALTO, Calif., June 13, 2022--Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by SoftBank and its affiliates, giving the company full control over operations throughout the Asia, Middle East and Africa region.

  • Motley Fool

    Why Shares of Guardant Health Dropped 33.6% in May

    It's a bit early for investors to jump the ship regarding Guardant because the biotech stock still has plenty of good long-term prospects. The test will compete with the Galleri blood-based cancer screening by the Grail unit of Illumina and a the Cologuard fecal screening by Exact Sciences. Investors are also watching the outcome of a lawsuit, filed in March by Illumina, that claims that Guardant and two of its founders -- former employees of Illumina -- used Illumina's propriety information to help them launch Guardant.

  • Business Wire

    Guardant Health to Participate in Upcoming June Investor Conferences

    REDWOOD CITY, Calif., May 26, 2022--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.